These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22690794

  • 1. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
    von Haehling S, Papassotiriou J, Hartmann O, Doehner W, Stellos K, Geisler T, Wurster T, Schuster A, Botnar RM, Gawaz M, Bigalke B.
    Clin Sci (Lond); 2012 Nov; 123(10):601-10. PubMed ID: 22690794
    [Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3. Multiple marker approach to risk stratification in patients with stable coronary artery disease.
    Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wollert KC, Benjamin EJ, Lackner KJ, Münzel TF, Tiret L, Vasan RS, Blankenberg S.
    Eur Heart J; 2010 Dec 13; 31(24):3024-31. PubMed ID: 20852293
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T.
    J Card Fail; 2007 Feb 13; 13(1):42-9. PubMed ID: 17339002
    [Abstract] [Full Text] [Related]

  • 5. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 6. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S, Keller T, Ojeda FM, Zeller T, Wild PS, Lubos E, Kunde J, Baldus S, Bickel C, Lackner KJ, Münzel TF, Blankenberg S.
    Heart; 2013 Mar 18; 99(6):388-95. PubMed ID: 23213173
    [Abstract] [Full Text] [Related]

  • 7. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P, Reichlin T, Irfan A, Reiter M, Zellweger C, Meissner J, Stelzig C, Freese M, Capodarve I, Mueller C.
    Am J Cardiol; 2012 Apr 15; 109(8):1117-23. PubMed ID: 22257708
    [Abstract] [Full Text] [Related]

  • 8. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528
    [Abstract] [Full Text] [Related]

  • 9. Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease.
    von Haehling S, Papassotiriou J, Morgenthaler NG, Hartmann O, Doehner W, Stellos K, Wurster T, Schuster A, Nagel E, Gawaz M, Bigalke B.
    Int J Cardiol; 2012 Dec 15; 162(1):27-32. PubMed ID: 22284271
    [Abstract] [Full Text] [Related]

  • 10. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M.
    J Am Coll Cardiol; 2010 Sep 21; 56(13):1045-53. PubMed ID: 20846604
    [Abstract] [Full Text] [Related]

  • 11. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
    Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Müller B, Schuetz P.
    Int J Cardiol; 2012 Apr 05; 156(1):16-23. PubMed ID: 21093937
    [Abstract] [Full Text] [Related]

  • 12. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA.
    J Am Coll Cardiol; 2014 Apr 29; 63(16):1644-53. PubMed ID: 24530676
    [Abstract] [Full Text] [Related]

  • 13. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G, Conte M, Marchitti S, Montone RA, Fracassi F, Grippo R, Roberto M, Burzotta F, Trani C, Leone AM, Bianchi F, Di Castro S, Volpe M, Crea F, Rubattu S.
    Cardiovasc Revasc Med; 2016 Apr 29; 17(3):162-8. PubMed ID: 26987266
    [Abstract] [Full Text] [Related]

  • 14. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T, CAPNETZ Study Group.
    Thorax; 2010 Mar 29; 65(3):208-14. PubMed ID: 20335288
    [Abstract] [Full Text] [Related]

  • 15. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
    Kiliç T, Ural E, Oner G, Sahin T, Kiliç M, Yavuz S, Kanko M, Kahraman G, Bildirici U, Berki KT, Ural D.
    Anadolu Kardiyol Derg; 2009 Aug 29; 9(4):280-9. PubMed ID: 19666429
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM, Camargo PV, Borges FK, Rossini AP, Polanczyk CA.
    Coron Artery Dis; 2010 May 29; 21(3):129-36. PubMed ID: 20305551
    [Abstract] [Full Text] [Related]

  • 17. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A, Caputo M, Fineschi M, Navarri R, Calabrò A, Cameli M, Campagna MS, Franci B, Pierli C, Nuti R, Maisel A.
    Eur J Prev Cardiol; 2012 Jun 29; 19(3):366-73. PubMed ID: 21464097
    [Abstract] [Full Text] [Related]

  • 18. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E, Wuppinger T, Bode T, Alber H, Ulmer H, Pachinger O, Mair J.
    Coron Artery Dis; 2012 Mar 29; 23(2):91-7. PubMed ID: 22157356
    [Abstract] [Full Text] [Related]

  • 19. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 20. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
    Daniels LB, Clopton P, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Anand IS, Wu AH, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Filippatos GS, Di Somma S, Ng L, Neath SX, Christenson R, Morgenthaler NG, Anker SD, Maisel AS.
    Eur J Heart Fail; 2012 Jan 12; 14(1):22-31. PubMed ID: 22140234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.